A股午評:滬指升0.2% 保險、醫藥股普升 中國平安升近6.8%強勢領升
格隆匯4月27日丨A股三大指數午間收盤多數收升,上證指數升0.2%,報3271點,創業板指升0.12%,深證成指跌0.11%,滬深兩市上升2581股,下跌2152股,兩市成交額6305億,北上淨賣出29.23億元。盤面上,保險板塊強勢大升,中國平安一季度淨利同比增長48.9%,升6.8%強勢領升;半導體板塊回升,國科微一季度業績扭虧為盈升11%;電力、電池等部分新能源方向繼續走強,基建、中藥、化學制藥等股大升。 此外,AI概念股繼續調整,ChatGPT、算力方向以及傳媒、遊戲等應用方向紛紛大幅回調;白酒板塊走弱,老白乾酒績後逼近跌停;液冷概念股、銀行、煤炭、消費電子等股下跌。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.